|4Jun 5, 5:23 PM ET

Obrocea Mihail 4

4 · MAIA Biotechnology, Inc. · Filed Jun 5, 2023

Insider Transaction Report

Form 4
Period: 2023-05-31
Obrocea Mihail
Chief Medical Officer
Transactions
  • Award

    Stock Options

    2023-05-31+87,49587,495 total
    Exercise: $2.50From: 2023-05-31Exp: 2032-05-30Common Stock (87,495 underlying)
Footnotes (1)
  • [F1]The stock options, granted on May 31, 2023 pursuant to MAIA Biotechnology, Inc's 2021 Equity Incentive Plan, representing the right to buy shares of common stock, vest 100% on the date of the grant and are exercisable beginning as of that date.

Documents

1 file
  • 4
    form4.xmlPrimary

    PRIMARY DOCUMENT